Investor Overview

Pardes is a clinical-stage biopharmaceutical company created by and for this moment to solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covalent chemistry as a starting point to develop novel drugs while reimagining the patient journey to access these medicines.

Stock
Quote

Webcasts

06/09/2022
at 11:30 AM EDT
03/09/2022
at 11:10 AM PST
02/15/2022
at 3:00 PM PST

Financial Information

Document Date Description Form View

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

DRS View HTML

Registration statement for face-amount certificate companies

S-1 View HTML

Amended Registration statement for face-amount certificate companies

S-1/A View HTML

Registration of certain classes of securities 12(b) of the Securities Exchange Act

8-A12B View HTML

Registration of up to an additional 20% of securities for any offering registered on an S-1

S-1MEF View HTML

Initial filing by director officer or owner of more than ten percent.

3 View HTML

Initial filing by director officer or owner of more than ten percent.

3 View HTML

Initial filing by director officer or owner of more than ten percent.

3 View HTML

Initial filing by director officer or owner of more than ten percent.

3 View HTML

Initial filing by director officer or owner of more than ten percent.

3 View HTML

Contact
IR

Send us an investor-related question using the form below.